Trials / Conditions / Moderate Plaque Psoriasis
Moderate Plaque Psoriasis
4 registered clinical trials studyying Moderate Plaque Psoriasis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants NCT06333860 | AbbVie | Phase 4 |
| Active Not Recruiting | Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque NCT06247319 | AbbVie | — |
| Completed | Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis NCT06039189 | Janssen Research & Development, LLC | Phase 3 |
| Completed | A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Stud NCT03059953 | Genesis Pharma S.A. | — |